Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
MEDICINES CO (MDCO)
|
Add to portfolio |
|
|
|
| Price: |
$84.71
| | Metrics |
| OS: |
79.7
|
M
| |
|
|
| Market cap: |
$6.75
|
B
| |
-136
|
% ROIC
|
|
Net cash:
|
$172
|
M
| |
$2.16
|
per share
|
|
EV:
|
$6.58
|
B
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
($176)
|
M
| |
|
|
|
EBIT
|
($179)
|
M
| |
|
|
| EPS |
($4.81)
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 | Dec-31-13 | Dec-31-12 | Dec-31-11 |
| Revenues | 6.1 | 44.8 | 143.2 | 294.5 | 659.7 | 624.6 | 558.6 | 484.7 |
| Revenue growth | -86.3% | -68.7% | -51.4% | -55.4% | 5.6% | 11.8% | 15.2% | 10.8% |
| Cost of goods sold | 7.3 | 47.2 | 60.7 | 104.0 | 233.3 | 216.6 | 177.3 | 156.9 |
| Gross profit | -1.1 | -2.4 | 82.5 | 190.6 | 426.4 | 408.0 | 381.2 | 327.9 |
| Gross margin | -18.2% | -5.4% | 57.6% | 64.7% | 64.6% | 65.3% | 68.3% | 67.6% |
| Selling, general and administrative | 52.2 | 132.2 | 212.5 | 285.3 | 315.0 | 247.8 | 171.8 | 159.6 |
| Research and development | 133.0 | 138.4 | 92.1 | 90.4 | 139.5 | 138.3 | 126.4 | 110.2 |
| EBITA | -186.3 | -268.5 | -204.6 | -170.1 | 28.1 | 35.7 | 87.5 | 78.7 |
| EBITA margin | -3035.8% | -599.5% | -142.9% | -57.8% | 4.3% | 5.7% | 15.7% | 16.2% |
| Amortization of intangibles | | 4.5 | 17.5 | 10.0 | 32.2 | 13.8 | 4.4 | 2.6 |
| EBIT | -186.3 | -273.0 | -222.1 | -180.1 | -4.1 | 21.9 | 83.1 | 76.1 |
| EBIT margin | -3035.8% | -609.5% | -155.1% | -61.2% | -0.6% | 3.5% | 14.9% | 15.7% |
| Pre-tax income | -286.1 | -704.3 | 20.6 | -164.5 | -2.1 | 25.2 | 86.2 | 77.8 |
| Income taxes | -50.9 | -96.6 | 0.1 | -29.7 | -2.3 | 2.3 | -35.0 | -50.0 |
| Tax rate | 17.8% | 13.7% | 0.3% | 18.1% | 108.5% | 9.0% | | |
| Earnings from continuing ops | -358.4 | -708.4 | -119.1 | -134.8 | 0.3 | 38.4 | 51.2 | 127.9 |
| Earnings from discontinued ops | | | | -218.0 | -32.5 | | | |
| Net income | -358.4 | -708.4 | -119.1 | -352.8 | -32.2 | 38.4 | 51.2 | 127.9 |
| Net margin | -5838.6% | -1581.6% | -83.2% | -119.8% | -4.9% | 6.1% | 9.2% | 26.4% |
| |
| Diluted EPS | ($4.87) | ($9.79) | ($1.63) | ($2.02) | $0.00 | $0.61 | $0.92 | $2.35 |
| Shares outstanding (diluted) | 73.6 | 72.4 | 73.0 | 66.8 | 66.7 | 62.7 | 55.3 | 54.4 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|